Aralez Pharmaceuticals Inc. (TSX:ARZ) intends to pursue acquisitions. "So in the event that we are able to identify assets that are either revenue generating or EBITDA accretive, we will continue to look at that in addition to potential M&A opportunities. But also I think as part of that, in the event that we are able to be kind of bring in diamonds in the rough so to speak like ZONTIVITY that drive that organic growth we are very keen on doing that," Adrian Adams, Chief Executive Officer, said.